A study of using carbon nanoparticles to improve lymph nodes staging for laparoscopic-assisted radical right hemicolectomy in colon cancer
- 75 Downloads
This study aimed to analyze and evaluate the feasibility of using carbon nanoparticles (CNs) to track lymph nodes (LNs) metastases in right colon tumors, especially for patients who underwent laparoscopic-assisted radical right hemicolectomy.
A total of 99 patients were enrolled in this retrospective study between November 2015 and September 2017 (control group n = 47). One day before surgery, 1 ml of CNs suspension was injected into the submucosal layer around the site of the primary lesions by colonoscopy. Then complete mesocolic excision (CME) of laparoscopic right hemicolectomy was performed. CNs-stained LNs were identified and counted from all dissected LNs after surgery.
The dates showed that the number of total harvested LNs and the number of positive patients in the experimental group increased significantly compared with the control group (respectively, P < 0.01 and P < 0.05). The increase of positive percentage shifted some patients toward higher stage, although the total number of positive LNs changed a little bit. In addition, the duration for pathologist to dissect LNs became shorter (26.4 vs. 31.1 min, P < 0.05).
Therefore, the CNs are not only a good tattoo in laparoscopic-assisted operation, but could be regarded as a better pathological evaluating tool for tumor treatment.
KeywordsCarbon nanoparticles Lymph node Laparoscopic right hemicolectomy Colon cancer
This study is supported by Natural Science Foundation of Zhejiang Province of China (No. LY18H160018).
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
- 4.Wang Y, Deng H, Chen H, Liu H, Xue Q, Yan J, Li G (2015) Preoperative submucosal injection of carbon nanoparticles improves lymph node staging accuracy in rectal cancer after neoadjuvant chemoradiotherapy. J Am Coll Surg 221(5):923–930. https://doi.org/10.1016/j.jamcollsurg.2015.07.455 CrossRefPubMedGoogle Scholar
- 5.Benson AB, Venook AP, Cederquist L, Chan E, Chen Y-J, Cooper HS, Deming D, Engstrom PF, Enzinger PC, Fichera A, Grem JL, Grothey A, Hochster HS, Hoffe S, Hunt S, Kamel A, Kirilcuk N, Krishnamurthi S, Messersmith WA, Mulcahy MF, Murphy JD, Nurkin S, Saltz L, Sharma S, Shibata D, Skibber JM, Sofocleous CT, Stoffel EM, Stotsky-Himelfarb E, Willett CG, Wu CS, Gregory KM, Freedman-Cass D (2017) Colon Cancer, version 1.2017, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw 15(3):370–398. https://doi.org/10.3109/21691401.2015.1105239 CrossRefGoogle Scholar
- 6.Rullier A, Laurent C, Capdepont M, Vendrely V, Belleannée G, Bioulac-Sage P, Rullier E (2008) Lymph nodes after preoperative chemoradiotherapy for rectal carcinoma: number, status, and impact on survival. Am J Surg Pathol 32(1):45–50. https://doi.org/10.1097/PAS.0b013e3180dc92ab CrossRefPubMedGoogle Scholar
- 9.La Torre M, Mazzuca F, Ferri M, Mari FS, Botticelli A, Pilozzi E, Lorenzon L, Osti MF, Marchetti P, Enrici RM, Ziparo V (2013) The importance of lymph node retrieval and lymph node ratio following preoperative chemoradiation of rectal cancer. Color Dis 15(7):e382–e388. https://doi.org/10.1111/codi.12242 CrossRefGoogle Scholar